Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: David Israel-Rosen who wrote (106)	11/6/1998 8:04:00 PM
From: Rick Strange	Read Replies (2) \| Respond to of 1386

David, In June of 1997, Merrill Lynch purchased 19% of Agis Industries from the Arkin family for various clients. Moshe Arkin said that the sale is part of an effort to internationalise trade in the company's shares. This effort could include a future offering of Agis shares on NASDAQ, though there are no definite plans yet for such a float. Does anyone know if the shares of PARS purchased by Agis were market transactions or a cross involving C.C? Was Merrill Lynch involved in the transaction?